Literature DB >> 19902529

Interactions between quercetin and warfarin for albumin binding: A new eye on food/drug interference.

Lorenzo Di Bari1, Silvia Ripoli, Sanghamitra Pradhan, Piero Salvadori.   

Abstract

The interaction between quercetin, a popular antioxidant flavonoid, and human serum albumin (HSA) is investigated and characterized by means of induced circular dichroism and saturation transfer difference NMR. These techiques demonstrate the reversible binding of quercetin to the carrier protein, which is responsible for its dissolution in aqueous medium. Competition experiments with two classical probes for HSA binding sites, namely Ibuprofen and Warfarin (a common anticoagulant coumarin), demonstrate that quercetin has a primary binding site located in the subdomain IIA, where coumarins are hosted. The affinity for this site is large and we found that quercetin may effectively displace warfarin from HSA. This may have relevant consequences in rationalizing the interferences of common dietary compounds and food supplements to anticoagulant treatments. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19902529     DOI: 10.1002/chir.20794

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  9 in total

1.  Clinically relevant interaction between warfarin and scuppernongs, a quercetin containing muscadine grape: continued questions surrounding flavonoid-induced warfarin interactions.

Authors:  Christopher J Woodward; Zachariah M Deyo; Katrina E Donahue; Allison M Deal; Emily M Hawes
Journal:  BMJ Case Rep       Date:  2014-06-25

2.  Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.

Authors:  Kelly E Beazley; Derek Banyard; Florence Lima; Stephanie C Deasey; Dmitry I Nurminsky; Mikhail Konoplyannikov; Maria V Nurminskaya
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-01       Impact factor: 8.311

3.  Protein-Flavonoid Interaction Studies by a Taylor Dispersion Surface Plasmon Resonance (SPR) Technique: A Novel Method to Assess Biomolecular Interactions.

Authors:  Preejith P Vachali; Binxing Li; Brian M Besch; Paul S Bernstein
Journal:  Biosensors (Basel)       Date:  2016-02-25

4.  Predicting drug-drug interactions through drug structural similarities and interaction networks incorporating pharmacokinetics and pharmacodynamics knowledge.

Authors:  Takako Takeda; Ming Hao; Tiejun Cheng; Stephen H Bryant; Yanli Wang
Journal:  J Cheminform       Date:  2017-03-07       Impact factor: 5.514

5.  Warfarin and Flavonoids Do Not Share the Same Binding Region in Binding to the IIA Subdomain of Human Serum Albumin.

Authors:  Hrvoje Rimac; Claire Dufour; Željko Debeljak; Branka Zorc; Mirza Bojić
Journal:  Molecules       Date:  2017-07-11       Impact factor: 4.411

6.  Fluorescence Spectroscopic Investigation of Competitive Interactions between Quercetin and Aflatoxin B₁ for Binding to Human Serum Albumin.

Authors:  Hongxia Tan; Lu Chen; Liang Ma; Shuang Liu; Hongyuan Zhou; Yuhao Zhang; Ting Guo; Wei Liu; Hongjie Dai; Yong Yu
Journal:  Toxins (Basel)       Date:  2019-04-09       Impact factor: 4.546

7.  Investigation of human albumin-induced circular dichroism in dansylglycine.

Authors:  Fernanda S Graciani; Valdecir F Ximenes
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

Review 8.  Study on the interaction between active components from traditional Chinese medicine and plasma proteins.

Authors:  Qishu Jiao; Rufeng Wang; Yanyan Jiang; Bin Liu
Journal:  Chem Cent J       Date:  2018-05-04       Impact factor: 4.215

Review 9.  The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence.

Authors:  Fatemeh Rezaei-Tazangi; Hossein Roghani-Shahraki; Mahdi Khorsand Ghaffari; Firoozeh Abolhasani Zadeh; Aynaz Boostan; Reza ArefNezhad; Hossein Motedayyen
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.